Inoxysyrup (Inosiplex)

Adult dose

Adults: Administer 3~4 g of inosiplex per day (60~80 mL of this medicine) orally in divided doses of 500 mg~1g (10~20 mL) every 4~6 hours.

Child dose

Children: Administer 50~100 mg/kg of body weight per day orally in 6 divided doses.

This medication should not be used by individuals who have had allergic reactions to this medication or its ingredients. Care should be taken when using this medication in individuals with gout or hyperuricemia, or with a history of such conditions, as blood uric acid levels may increase, worsening symptoms. People with urinary stones or kidney stones should also use this medication with caution, as there is a risk of worsening symptoms due to increased uric acid levels. Individuals with poor kidney function should use this medication carefully, as it may delay the body's excretion of uric acid. Those taking heart medication such as digitalis should be cautious, as this medication can affect the heart. This medication contains caramel, so individuals allergic to caramel or with sensitivities should use it carefully. Taking this medication may cause gastrointestinal symptoms such as digestive discomfort, diarrhea, constipation, nausea, vomiting, and abdominal pain. Changes in blood tests may occur, such as increased red blood cells, decreased white blood cells, and increased platelets. Liver function test results may rise, so care for liver health is necessary. Allergic reactions such as skin rashes may occur. Metabolic disorders resulting in increased uric acid levels may develop. It may affect the kidneys and urinary system, potentially leading to increased blood urea nitrogen (BUN), kidney stones, and frequent urination. Neurological symptoms such as headaches, dizziness, fatigue, irritability, drowsiness, and insomnia may also be experienced. Joint pain or rarely, interstitial pneumonia causing lung inflammation may occur, so caution is advised. This medication may increase uric acid levels in blood and urine, so it is advisable to regularly check uric acid levels and kidney function during treatment. There are not many significant interactions with other medications, but it should be avoided in combination with cortisone, globulin, immunosuppressants, and anti-lymphocyte globulin. Women who are pregnant or may become pregnant should only use this medication when the benefits outweigh the risks, as its safety is not established, especially during the first three months of pregnancy. Additionally, this medication can be passed into breast milk, so it is preferable to stop administration during breastfeeding. In case of overdose, symptoms such as vomiting, headache, abdominal discomfort, dizziness, and palpitations may occur; however, reducing or stopping the dose should resolve the symptoms. In case of overdose, treatment to relieve symptoms should be given concurrently.

Upper abdominal discomfort, diarrhea, constipation, gastrointestinal bleeding, nausea, vomiting, abdominal pain, increased red blood cells, decreased white blood cells, increased platelets, elevation of AST/ALT, elevation of γ-GTP, elevation of ALP, elevation of LDH, rash, hyperuricemia, increased BUN, kidney stones accompanied by hypercalcemia, polyuria, urinary stones, headache, dizziness, fatigue, malaise, nervous irritability, drowsiness, insomnia, joint pain, interstitial pneumonia, palpitations

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature.

Appearance

A colorless to light brown syrup with a caramel flavor

Package unit

500mL/bottle